News
Research reveals potential new link to signs of skin ageing

New research has identified the skin microbiome as a potential new link to signs of skin ageing.
To the best of the researchers’ knowledge, the study is the first to isolate microbes associated specifically with signs of skin ageing and skin health, rather than chronological age.
The results come from a collaborative study from researchers at the Center for Microbiome Innovation (CMI) at the University of California San Diego (UC San Diego) and L’Oréal Research and Innovation.
Corresponding author, Se Jin Song, the CMI Director of Research, said: “Previous studies have shown that the types of microbes on our skin change fairly predictably with age.
“Our skin also changes physiologically with age; for example, we gain wrinkles and our skin gets drier.
“But there is variation in what this looks like in people—you’ve probably noticed that there are some people who have younger or older looking skin than many others their age.
“Using advanced statistical methods, we were able to tease apart the microbes that are associated with these types of ageing signs for skin, like crow’s feet wrinkles, from those that are associated with simply age as a chronological number.”
The researchers comprehensively examined data collected during 13 studies that L’Oréal had carried out in the past, consisting of 16S rRNA amplicon sequence data and corresponding skin clinical data for over 650 female participants, aged 18 – 70.
While each of the studies included in the analysis had focused on one particular area of interest—for example, crow’s feet wrinkles or moisture loss—the multi-study analysis collated the data to search for trends related to specific microbes while accounting for other variables, such as age.
The analysis revealed two notable trends.
Firstly, the team found a positive association between skin microbiome diversity and lateral cantonal lines (crow’s feet wrinkles), which are generally viewed as one of the key signs of skin ageing.
Secondly, they observed a negative correlation between microbiome diversity and transepidermal water loss, which is the amount of moisture that evaporates through the skin.
In further exploring the trends, the research team identified several potential biomarkers that warrant investigation as microorganisms of interest.
It would be premature to infer causation or actionable insights, but the findings have provided researchers with directions on the next steps to hone in on better understanding microbial associations with skin ageing.
Qian Zheng, Head of Advanced Research, North America at L’Oréal, is co-authors of the study.
The researcher said: “This research is ground-breaking in identifying new microbial biomarkers linked to visible signs of ageing like crow’s feet wrinkles.
“It marks a significant step towards developing technologies for healthier, more youthful skin.
“We look forward to sharing new results as they become available, furthering the scientific community’s understanding and contributing to advancing new skincare solutions.”
Future paths of investigation the researchers have suggested include metabolomics work to discover chemical biomarkers related to skin ageing, as well as meta-transcriptomics research into potential targets for genetic engineering.
Research into other layers of the skin is also being considered, as many studies focus on the outer skin due to the ease of sample collection.
Rob Knight, the CMI Faculty Director and Professor of Pediatrics, Bioengineering, Computer Science & Engineering and Data Science at UC San Diego, co-authored the study.
He said: “While the study’s findings represent an advance of our knowledge of the skin microbiome, we view them as just the beginning of a new phase of research.
“By confirming a link between the microbiome and skin health, we’ve laid the groundwork for further studies that discover specific microbiome biomarkers related to skin ageing, and, one day, show how to modify them to generate novel and highly targeted recommendations for skin health.”
News
Gut-friendly foods may damage heart, charity warns
News
Diabetes patients face increased risk of undiagnosed heart failure

People with diabetes may have undiagnosed heart failure that could be detected by a simple screening blood test, research suggests.
The TARTAN-HF trial found that one in four patients with diabetes who had at least one other risk factor for heart failure had undiagnosed heart failure detected through screening with a blood test and ultrasound scanning of the heart.
Experts said the findings show the extent of unrecognised heart failure in people with diabetes, and how the condition can be detected using a widely available blood test called NT-proBNP, which measures how much strain the heart is under.
They suggest a heart failure screening programme for diabetics could improve diagnosis rates, lead to earlier treatment and potentially reduce the risk of hospitalisation and death.
The study, involving 700 patients, was led by the University of Glasgow in collaboration with AstraZeneca, Roche Diagnostics, Us2.ai, NHS Greater Glasgow and Clyde and NHS Lanarkshire.
Dr Kieran Docherty, clinical senior lecturer at the University of Glasgow’s School of Cardiovascular and Metabolic Health, said: “Our results from the landmark TARTAN-HF trial identified heart failure in a large proportion of people living with diabetes, emphasising the need for a heart failure screening strategy in this group of patients.
“We know that many of the symptoms and signs of heart failure are non-specific, and may go unrecognised as potentially being due to heart failure for a long time.
“The strategy used in our trial is simple and easy to implement in clinical practice, and will aid in the early identification of heart failure in people with diabetes, and facilitate the initiation of medications that we know improve outcomes in patients with heart failure.”
The study, which began more than three years ago, involved more than 700 people with diabetes from the two health board areas who had at least one other risk factor for heart failure.
They were randomly assigned either to receive heart failure screening or to continue with their usual care.
Researchers found screening uncovered a large number of previously unrecognised cases of heart failure. Around one in four, or 24.9 per cent, of those screened were found to have the condition within six months, compared with 1 per cent in the group continuing their usual care.
The study, involving patients with type 1 and type 2 diabetes, found almost all of the participants found to have heart failure had preserved ejection fraction, which can be difficult to detect without dedicated testing.
The findings of the TARTAN-HF trial were presented at the American College of Cardiology conference taking place from 28 to 30 March in New Orleans in the US.
Dr Edward Piper, medical director at AstraZeneca UK, said: “Delayed diagnosis and treatment of heart failure in people with type 2 diabetes contributes to poor long-term outcomes. TARTAN-HF demonstrates that targeted, risk-based screening can identify previously undiagnosed heart failure in approximately one in four high-risk patients with diabetes, enabling earlier intervention with guideline-directed therapy.”
Dr Christian Simon, head of global medical affairs at Roche Diagnostics, said: “We are proud to have supported the landmark TARTAN-HF trial. These findings demonstrate the transformative power of early, accessible diagnostics like the NT-proBNP blood test.
“By identifying unrecognised heart failure in people with diabetes, we enable clinicians to initiate appropriate treatments sooner, ultimately improving patient outcomes and lives.”
News
UK government announces £6.3m fund to boost men’s health

The UK has launched a £6.3m men’s health fund to back local projects aimed at helping men and boys live longer, healthier lives.
The Men’s Health Community Fund is a partnership between the Department of Health and Social Care, Movember and People’s Health Trust.
The government is contributing £3m, while the two charities are more than doubling that to take the total to £6.3m.
Grants will support community projects reaching underserved men and boys aged 16 and over, particularly in the most disadvantaged areas and at key points in their lives such as becoming a father, losing a job or retiring.
Projects could include support for new fathers, activities for men facing loneliness and social isolation, services to help young men engage with the health system, and support for men in work, out of work and moving into retirement.
The programme will bring together voluntary, community and social enterprise organisations to test new ways of reaching men who are least likely to use traditional health services.
An evaluation funded through the National Institute for Health and Care Research will assess what works and help inform future policy and delivery.
Health and social care secretary Wes Streeting said: “Too many men across the country are living shorter, less healthy lives, particularly those in our most disadvantaged communities.
“This new partnership will help men get the support they need in the places they feel most comfortable, their communities, among people they trust.
“By working with expert charities and local organisations, we can reach the men who are too often missed by traditional services and help them take better care of their mental and physical health.”
“It is a key step in delivering our first ever Men’s Health Strategy and driving forward our ambition to halve the gap in healthy life expectancy between the richest and poorest areas.”
The Men’s Health Strategy sets out plans to tackle the physical and mental health challenges men and boys face.
Men can be less likely to seek help and more likely to suffer in silence, while higher rates of smoking, drinking, gambling and drug use are damaging men’s health and affecting families, workplaces and communities.
The government is also investing £3.6m over the next three years in suicide prevention projects for middle-aged men in local communities across areas of England where men are most at risk, many of which are also among the most deprived. Suicide is one of the biggest killers of men under 50, and three-quarters of all suicides are men.
The projects will aim to break down barriers middle-aged men face in seeking support, including stigma around asking for help and a lack of awareness of what is available and how to access it.
They will be co-designed with experts and men with lived experience of mental health crises and suicidal thoughts.









